NCT01243892View on ClinicalTrials.gov

A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device

TerminatedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Growth Hormone Deficiency
Interventions
DEVICE

NuSpin

Device for administration of doses of somatropin.

DRUG

Somatropin

Somatropin using either NuSpin or Nutropin AQ Pen, as per standard dosing.

Trial Locations (14)

10549

Mount Kisco

10801

New Rochelle

30342

Atlanta

32905

Palm Bay

33028

Pembrook Pines

35233

Birmingham

37916

Knoxville

43235

Columbus

55455

Minneapolis

60187

Wheaton

80111

Greenwood Village

85258

Scottsdale

92123

San Diego

95819

Sacramento

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT01243892 - A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device | Biotech Hunter | Biotech Hunter